DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 200 filers reported holding DENALI THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 9.23 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $59,662 | -41.3% | 2,891,950 | -16.1% | 0.01% | -35.7% |
| Q2 2023 | $101,672 | +24.7% | 3,445,312 | -2.6% | 0.01% | +16.7% |
| Q1 2023 | $81,511 | -19.7% | 3,537,778 | -3.0% | 0.01% | -25.0% |
| Q4 2022 | $101,475 | -99.9% | 3,648,888 | +4.9% | 0.02% | -5.9% |
| Q3 2022 | $106,752,000 | -21.3% | 3,478,368 | -24.6% | 0.02% | 0.0% |
| Q2 2022 | $135,678,000 | -14.3% | 4,610,177 | -6.4% | 0.02% | +6.2% |
| Q1 2022 | $158,387,000 | -23.4% | 4,923,425 | +6.2% | 0.02% | -15.8% |
| Q4 2021 | $206,740,000 | -13.9% | 4,635,433 | -2.6% | 0.02% | -17.4% |
| Q3 2021 | $240,039,000 | -37.6% | 4,757,965 | -3.0% | 0.02% | -36.1% |
| Q2 2021 | $384,627,000 | +11.2% | 4,903,452 | -19.1% | 0.04% | +2.9% |
| Q1 2021 | $345,928,000 | -36.1% | 6,058,279 | -6.3% | 0.04% | -37.5% |
| Q4 2020 | $541,494,000 | +246.5% | 6,464,826 | +48.2% | 0.06% | +211.1% |
| Q3 2020 | $156,254,000 | +146.4% | 4,360,975 | +66.3% | 0.02% | +125.0% |
| Q2 2020 | $63,404,000 | +199.0% | 2,622,162 | +116.5% | 0.01% | +166.7% |
| Q1 2020 | $21,205,000 | +191.8% | 1,211,039 | +190.3% | 0.00% | +200.0% |
| Q4 2019 | $7,267,000 | +7.8% | 417,156 | -5.2% | 0.00% | 0.0% |
| Q3 2019 | $6,744,000 | -32.5% | 440,197 | -8.5% | 0.00% | 0.0% |
| Q2 2019 | $9,988,000 | -10.6% | 481,140 | -0.0% | 0.00% | -50.0% |
| Q1 2019 | $11,177,000 | +13.4% | 481,342 | +0.9% | 0.00% | 0.0% |
| Q4 2018 | $9,860,000 | -4.7% | 477,242 | +0.2% | 0.00% | 0.0% |
| Q3 2018 | $10,350,000 | +86.6% | 476,067 | +30.9% | 0.00% | +100.0% |
| Q2 2018 | $5,548,000 | -24.2% | 363,825 | -2.1% | 0.00% | 0.0% |
| Q1 2018 | $7,321,000 | – | 371,806 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 19,462,500 | $339,037,000 | 35.95% |
| Euclidean Capital LLC | 323,749 | $27,117,000 | 5.74% |
| Flagship Pioneering Inc. | 2,730,263 | $228,687,000 | 4.16% |
| Casdin Capital, LLC | 1,310,000 | $109,726,000 | 3.25% |
| A.R.T. Advisors, LLC | 6,173 | $517,000 | 2.39% |
| MARK ASSET MANAGEMENT LP | 172,040 | $14,410,000 | 1.73% |
| Temasek Holdings (Private) Ltd | 4,410,457 | $369,420,000 | 1.59% |
| Integral Health Asset Management, LLC | 57,500 | $4,816,000 | 1.43% |
| GILDER GAGNON HOWE & CO LLC | 3,219,843 | $269,694,000 | 1.34% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 19,365 | $1,622,000 | 0.95% |